Get notified when APUS files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Delisting (new) — Company received formal NYSE notice of non-compliance with listing standards due to late 10-K filing.
NYSE: APUS Apimeds Pharmaceuticals US, Inc. 8-K

Apimeds receives NYSE delisting notice for late 2025 annual report; stock halted since April 2

Filed April 22, 2026 · Period ending April 17, 2026 · ~1 min read

Key Changes

  • high

    NYSE notified company on April 17 of non-compliance due to failure to file 2025 annual report on time. Company has 6 months to file the 10-K or face delisting, with possible 6-month extension.

  • high

    Stock trading remains halted since April 2, 2026. When trading resumes, ticker will carry '.LF' suffix marking the company as a late filer until compliance is restored.

  • high

    Company cited ongoing financial statement preparation and additional auditor time needed as reasons for delay. Expects to file by April 30, 2026, but provides no assurance.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (CAG 10-K) is open in full — no account needed.

Partner

Trade APUS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify